Search

Your search keyword '"Rivas, Charlotte"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Rivas, Charlotte" Remove constraint Author: "Rivas, Charlotte"
43 results on '"Rivas, Charlotte"'

Search Results

1. Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal

2. Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of99mTc and188Re Theranostic Agents for Prostate Cancer

3. Unbiased metastatic niche-labeling identifies estrogen receptor-positive macrophages as a barrier of T cell infiltration during bone colonization

4. Single cell profiling of bone metastasis ecosystems from multiple cancer types reveals convergent and divergent mechanisms of bone colonization.

7. Dual-modal imaging agents for zinc ion sensing

16. Toward Bifunctional Chelators for Thallium-201 for Use in Nuclear Medicine

18. New Bifunctional Chelators Incorporating Dibromomaleimide Groups for Radiolabeling of Antibodies with Positron Emission Tomography Imaging Radioisotopes

20. 2019 Health Equity Summer Research Summit Organized by the Center of Excellence in Health Equity, Training and Research, Baylor College of Medicine, Houston, Texas 77030, USA on June 18th, 2019

26. Lanthanide(III) Complexes of Rhodamine–DO3A Conjugates as Agents for Dual-Modal Imaging

27. TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy

30. Dual‐Modal Magnetic Resonance/Fluorescent Zinc Probes for Pancreatic β‐Cell Mass Imaging

35. 99mTc SPECT imaging agent based on cFLFLFK for the detection of FPR1 in inflammation.

36. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016

37. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

38. TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy.

39. Dual-modal magnetic resonance/fluorescent zinc probes for pancreatic β-cell mass imaging

40. Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of 99m Tc and 188 Re Theranostic Agents for Prostate Cancer.

41. Unbiased metastatic niche-labeling identifies estrogen receptor-positive macrophages as a barrier of T cell infiltration during bone colonization.

42. Versatile Diphosphine Chelators for Radiolabeling Peptides with 99m Tc and 64 Cu.

43. Dual-modal magnetic resonance/fluorescent zinc probes for pancreatic β-cell mass imaging.

Catalog

Books, media, physical & digital resources